vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $220.8M, roughly 1.2× UNIVERSAL TECHNICAL INSTITUTE INC). UNIVERSAL TECHNICAL INSTITUTE INC runs the higher net margin — 5.8% vs 0.7%, a 5.1% gap on every dollar of revenue. On growth, UNIVERSAL TECHNICAL INSTITUTE INC posted the faster year-over-year revenue change (9.6% vs -16.5%). HUTCHMED (China) Ltd produced more free cash flow last quarter ($3.4M vs $-19.2M).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.
HCM vs UTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $220.8M |
| Net Profit | $2.0M | $12.8M |
| Gross Margin | 37.7% | — |
| Operating Margin | -13.2% | 7.1% |
| Net Margin | 0.7% | 5.8% |
| Revenue YoY | -16.5% | 9.6% |
| Net Profit YoY | -83.6% | -42.1% |
| EPS (diluted) | $0.00 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.8M | $220.8M | ||
| Q3 25 | — | $222.4M | ||
| Q2 25 | $277.7M | $204.3M | ||
| Q1 25 | $324.5M | $207.4M | ||
| Q4 24 | — | $201.4M | ||
| Q3 24 | — | $196.4M | ||
| Q2 24 | $305.7M | $177.5M | ||
| Q1 24 | — | $184.2M |
| Q4 25 | $2.0M | $12.8M | ||
| Q3 25 | — | $18.8M | ||
| Q2 25 | $455.0M | $10.7M | ||
| Q1 25 | $11.9M | $11.4M | ||
| Q4 24 | — | $22.2M | ||
| Q3 24 | — | $18.8M | ||
| Q2 24 | $25.8M | $5.0M | ||
| Q1 24 | — | $7.8M |
| Q4 25 | 37.7% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 48.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 41.1% | — | ||
| Q1 24 | — | — |
| Q4 25 | -13.2% | 7.1% | ||
| Q3 25 | — | 11.2% | ||
| Q2 25 | -1.3% | 6.9% | ||
| Q1 25 | -5.0% | 8.1% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | — | 13.3% | ||
| Q2 24 | -9.0% | 4.2% | ||
| Q1 24 | — | 6.1% |
| Q4 25 | 0.7% | 5.8% | ||
| Q3 25 | — | 8.4% | ||
| Q2 25 | 163.8% | 5.2% | ||
| Q1 25 | 3.7% | 5.5% | ||
| Q4 24 | — | 11.0% | ||
| Q3 24 | — | 9.6% | ||
| Q2 24 | 8.4% | 2.8% | ||
| Q1 24 | — | 4.2% |
| Q4 25 | $0.00 | $0.23 | ||
| Q3 25 | — | $0.33 | ||
| Q2 25 | $0.52 | $0.19 | ||
| Q1 25 | $0.01 | $0.21 | ||
| Q4 24 | — | $0.40 | ||
| Q3 24 | — | $0.35 | ||
| Q2 24 | $0.03 | $0.09 | ||
| Q1 24 | — | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $162.8M |
| Total DebtLower is stronger | $93.2M | $101.4M |
| Stockholders' EquityBook value | $1.2B | $335.9M |
| Total Assets | $1.8B | $834.0M |
| Debt / EquityLower = less leverage | 0.08× | 0.30× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | $162.8M | ||
| Q3 25 | — | $169.1M | ||
| Q2 25 | $1.4B | $70.7M | ||
| Q1 25 | $836.1M | $96.0M | ||
| Q4 24 | — | $172.0M | ||
| Q3 24 | — | $161.9M | ||
| Q2 24 | $802.5M | $115.5M | ||
| Q1 24 | — | $116.1M |
| Q4 25 | $93.2M | $101.4M | ||
| Q3 25 | — | $87.1M | ||
| Q2 25 | $93.4M | $73.8M | ||
| Q1 25 | $82.8M | $94.4M | ||
| Q4 24 | — | $120.1M | ||
| Q3 24 | — | $125.7M | ||
| Q2 24 | $82.1M | $137.3M | ||
| Q1 24 | — | $141.9M |
| Q4 25 | $1.2B | $335.9M | ||
| Q3 25 | — | $328.1M | ||
| Q2 25 | $1.2B | $306.8M | ||
| Q1 25 | $759.9M | $293.9M | ||
| Q4 24 | — | $280.0M | ||
| Q3 24 | — | $260.2M | ||
| Q2 24 | $740.1M | $239.4M | ||
| Q1 24 | — | $232.6M |
| Q4 25 | $1.8B | $834.0M | ||
| Q3 25 | — | $826.1M | ||
| Q2 25 | $1.8B | $740.8M | ||
| Q1 25 | $1.3B | $720.4M | ||
| Q4 24 | — | $753.8M | ||
| Q3 24 | — | $744.6M | ||
| Q2 24 | $1.3B | $706.0M | ||
| Q1 24 | — | $702.1M |
| Q4 25 | 0.08× | 0.30× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | 0.08× | 0.24× | ||
| Q1 25 | 0.11× | 0.32× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 0.48× | ||
| Q2 24 | 0.11× | 0.57× | ||
| Q1 24 | — | 0.61× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $3.1M |
| Free Cash FlowOCF − Capex | $3.4M | $-19.2M |
| FCF MarginFCF / Revenue | 1.2% | -8.7% |
| Capex IntensityCapex / Revenue | 1.8% | 10.1% |
| Cash ConversionOCF / Net Profit | 4.21× | 0.24× |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | $16.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $3.1M | ||
| Q3 25 | — | $57.1M | ||
| Q2 25 | $-72.9M | $18.1M | ||
| Q1 25 | $40.3M | $-789.0K | ||
| Q4 24 | — | $23.0M | ||
| Q3 24 | — | $67.5M | ||
| Q2 24 | $-39.8M | $10.0M | ||
| Q1 24 | — | $-2.5M |
| Q4 25 | $3.4M | $-19.2M | ||
| Q3 25 | — | $40.6M | ||
| Q2 25 | $-82.2M | $6.8M | ||
| Q1 25 | $32.5M | $-11.7M | ||
| Q4 24 | — | $19.6M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | $-49.9M | $3.0M | ||
| Q1 24 | — | $-8.4M |
| Q4 25 | 1.2% | -8.7% | ||
| Q3 25 | — | 18.3% | ||
| Q2 25 | -29.6% | 3.4% | ||
| Q1 25 | 10.0% | -5.7% | ||
| Q4 24 | — | 9.7% | ||
| Q3 24 | — | 30.6% | ||
| Q2 24 | -16.3% | 1.7% | ||
| Q1 24 | — | -4.6% |
| Q4 25 | 1.8% | 10.1% | ||
| Q3 25 | — | 7.4% | ||
| Q2 25 | 3.3% | 5.5% | ||
| Q1 25 | 2.4% | 5.3% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 3.8% | ||
| Q2 24 | 3.3% | 4.0% | ||
| Q1 24 | — | 3.2% |
| Q4 25 | 4.21× | 0.24× | ||
| Q3 25 | — | 3.04× | ||
| Q2 25 | -0.16× | 1.69× | ||
| Q1 25 | 3.38× | -0.07× | ||
| Q4 24 | — | 1.04× | ||
| Q3 24 | — | 3.58× | ||
| Q2 24 | -1.54× | 2.01× | ||
| Q1 24 | — | -0.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HCM
Segment breakdown not available.
UTI
| UTI | $142.8M | 65% |
| Concorde | $78.0M | 35% |
